NCT03382821

Brief Summary

Do cervical epidural steroid injections done by transforaminal catheter targeted approach improve pain and function in patients with cervical radicular pain?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2017

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2017

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 26, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2020

Completed
7 months until next milestone

Results Posted

Study results publicly available

March 22, 2021

Completed
Last Updated

November 25, 2022

Status Verified

November 1, 2022

Enrollment Period

2.6 years

First QC Date

December 4, 2017

Results QC Date

August 19, 2020

Last Update Submit

November 22, 2022

Conditions

Keywords

cervical epidural steroid injectiontransforaminal approachepidural catheter targetedinterlaminar approachcervical radicular pain

Outcome Measures

Primary Outcomes (1)

  • The Percentage of Participants With Reduction of 50% or More of Neck and Arm Pain NRS Score

    The Percentage of Participants with Reduction of 50% or More of Neck and Arm Pain NRS score

    1 month follow up

Secondary Outcomes (3)

  • Neck Disability Index-5

    1 month, 3 month, 6 month, and 1 year follow up

  • Percentage of Participants Reporting >6.8 Reduction on the Medication Quantification Scale III

    1 month, 3 month, 6 month, and 1 year follow up

  • The Percentage of Participants Reporting Patient Global Impression of Change Score of 6-7 (Indicating "Much Improved" and "Very Much Improved")

    1 month, 3 month, 6 month, and 1 year follow up

Study Arms (2)

Transforaminal ESI with dexamethasone

ACTIVE COMPARATOR

Group 1: Transforaminal cervical ESI with dexamethasone sodium phosphate

Procedure: Transforaminal ESI with dexamethasoneDrug: Dexamethasone Sodium Phosphate 10 MG/MLDrug: Lidocaine

Transforaminal catheter-targeted ESI with triamcinolone

ACTIVE COMPARATOR

Group 2: Catheter-targeted cervical ESI with triamcinolone acetonide

Procedure: Transforaminal catheter-targeted ESI with triamcinoloneDrug: LidocaineDrug: Triamcinolone Acetonide 40mg/mL

Interventions

Catheter-targeted ESI via interlaminar access at the C7-T1 level with dexamethasone sodium phosphate 1.5 mL (10 mg/mL) and 1 ml 1% lidocaine (total volume 2.5 mL).

Transforaminal ESI with dexamethasone

Catheter-targeted ESI via interlaminar access at the C7-T1 level with triamcinolone acetonide 2 mL (40mg/mL) and 1 ml 1% lidocaine (total volume 3 mL).

Transforaminal catheter-targeted ESI with triamcinolone

Transforaminal ESI with dexamethasone 1.5 mL of dexamethasone sodium phosphate in group #1

Transforaminal ESI with dexamethasone

1 mL of 1% lidocaine as diluent for the steroid in both group #1 and group #2

Also known as: Xylocaine
Transforaminal ESI with dexamethasoneTransforaminal catheter-targeted ESI with triamcinolone

Transforaminal catheter-targeted ESI with triamcinolone acetonide 2 mL in group #2

Also known as: Kenalog
Transforaminal catheter-targeted ESI with triamcinolone

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80.
  • Clinical diagnosis of unilateral C4-C8 radicular pain.
  • Magnetic resonance imaging pathology consistent with clinical symptoms/signs.
  • Numerical Rating Scale (NRS) pain score of 4 or higher.
  • Pain duration of more than 6 weeks despite trial of conservative therapy (medications, physical therapy, or chiropractic care).

You may not qualify if:

  • Refusal to participate, provide consent, or provide follow-up information for the 6-month duration of the study.
  • Contraindications to Cervical Epidural Steroid Iinjection (CESI) (active infection, bleeding disorders, current anticoagulant or antiplatelet medication use, allergy to medications used for Cervical epidural steroid injection (CESI), and pregnancy).
  • Cervical spinal cord lesions; cerebrovascular, demyelinating, or other neuro-muscular muscular disease.
  • Current glucocorticoid use or Epidural Steroid Injection (ESI) within past 6 months.
  • Prior cervical spine surgery.
  • Patient request for or requirement of conscious sedation for the injection procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah Orthopaedic Center

Salt Lake City, Utah, 84108, United States

Location

Related Publications (29)

  • Radhakrishnan K, Litchy WJ, O'Fallon WM, Kurland LT. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain. 1994 Apr;117 ( Pt 2):325-35. doi: 10.1093/brain/117.2.325.

    PMID: 8186959BACKGROUND
  • Carette S, Fehlings MG. Clinical practice. Cervical radiculopathy. N Engl J Med. 2005 Jul 28;353(4):392-9. doi: 10.1056/NEJMcp043887. No abstract available.

    PMID: 16049211BACKGROUND
  • Heckmann JG, Lang CJ, Zobelein I, Laumer R, Druschky A, Neundorfer B. Herniated cervical intervertebral discs with radiculopathy: an outcome study of conservatively or surgically treated patients. J Spinal Disord. 1999 Oct;12(5):396-401.

    PMID: 10549703BACKGROUND
  • Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol. 2013 Jul;74(1):145-8. doi: 10.1002/ana.23869. Epub 2013 Jun 17.

    PMID: 23424170BACKGROUND
  • Mizutamari M, Sei A, Tokiyoshi A, Fujimoto T, Taniwaki T, Togami W, Mizuta H. Corresponding scapular pain with the nerve root involved in cervical radiculopathy. J Orthop Surg (Hong Kong). 2010 Dec;18(3):356-60. doi: 10.1177/230949901001800320.

    PMID: 21187551BACKGROUND
  • Rhee JM, Yoon T, Riew KD. Cervical radiculopathy. J Am Acad Orthop Surg. 2007 Aug;15(8):486-94. doi: 10.5435/00124635-200708000-00005.

    PMID: 17664368BACKGROUND
  • Malanga GA. The diagnosis and treatment of cervical radiculopathy. Med Sci Sports Exerc. 1997 Jul;29(7 Suppl):S236-45. doi: 10.1097/00005768-199707001-00006.

    PMID: 9247921BACKGROUND
  • Renfrew DL, Moore TE, Kathol MH, el-Khoury GY, Lemke JH, Walker CW. Correct placement of epidural steroid injections: fluoroscopic guidance and contrast administration. AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):1003-7.

    PMID: 1719788BACKGROUND
  • Mehta M, Salmon N. Extradural block. Confirmation of the injection site by X-ray monitoring. Anaesthesia. 1985 Oct;40(10):1009-12. doi: 10.1111/j.1365-2044.1985.tb10558.x.

    PMID: 4061788BACKGROUND
  • Stojanovic MP, Vu TN, Caneris O, Slezak J, Cohen SP, Sang CN. The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Spine (Phila Pa 1976). 2002 Mar 1;27(5):509-14. doi: 10.1097/00007632-200203010-00011.

    PMID: 11880836BACKGROUND
  • Van Zundert J, Huntoon M, Patijn J, Lataster A, Mekhail N, van Kleef M; Pain Practice. 4. Cervical radicular pain. Pain Pract. 2010 Jan-Feb;10(1):1-17. doi: 10.1111/j.1533-2500.2009.00319.x. Epub 2009 Oct 5.

    PMID: 19807874BACKGROUND
  • Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand. 1990 Jul;34(5):335-8. doi: 10.1111/j.1399-6576.1990.tb03097.x.

    PMID: 2167604BACKGROUND
  • Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician. 2009 Jan-Feb;12(1):137-57.

    PMID: 19165300BACKGROUND
  • Stav A, Ovadia L, Sternberg A, Kaadan M, Weksler N. Cervical epidural steroid injection for cervicobrachialgia. Acta Anaesthesiol Scand. 1993 Aug;37(6):562-6. doi: 10.1111/j.1399-6576.1993.tb03765.x.

    PMID: 8213020BACKGROUND
  • Castagnera L, Maurette P, Pointillart V, Vital JM, Erny P, Senegas J. Long-term results of cervical epidural steroid injection with and without morphine in chronic cervical radicular pain. Pain. 1994 Aug;58(2):239-243. doi: 10.1016/0304-3959(94)90204-6.

    PMID: 7816491BACKGROUND
  • Saal JS, Saal JA, Yurth EF. Nonoperative management of herniated cervical intervertebral disc with radiculopathy. Spine (Phila Pa 1976). 1996 Aug 15;21(16):1877-83. doi: 10.1097/00007632-199608150-00008.

    PMID: 8875719BACKGROUND
  • Riew KD, Yin Y, Gilula L, Bridwell KH, Lenke LG, Lauryssen C, Goette K. The effect of nerve-root injections on the need for operative treatment of lumbar radicular pain. A prospective, randomized, controlled, double-blind study. J Bone Joint Surg Am. 2000 Nov;82(11):1589-93. doi: 10.2106/00004623-200011000-00012.

    PMID: 11097449BACKGROUND
  • Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am. 2004 Apr;86(4):670-9.

    PMID: 15069129BACKGROUND
  • Huntoon MA. Anatomy of the cervical intervertebral foramina: vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain. 2005 Sep;117(1-2):104-11. doi: 10.1016/j.pain.2005.05.030.

    PMID: 16055268BACKGROUND
  • Abbasi A, Malhotra G, Malanga G, Elovic EP, Kahn S. Complications of interlaminar cervical epidural steroid injections: a review of the literature. Spine (Phila Pa 1976). 2007 Sep 1;32(19):2144-51. doi: 10.1097/BRS.0b013e318145a360.

    PMID: 17762818BACKGROUND
  • Rathmell JP, Benzon HT, Dreyfuss P, Huntoon M, Wallace M, Baker R, Riew KD, Rosenquist RW, Aprill C, Rost NS, Buvanendran A, Kreiner DS, Bogduk N, Fourney DR, Fraifeld E, Horn S, Stone J, Vorenkamp K, Lawler G, Summers J, Kloth D, O'Brien D Jr, Tutton S. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology. 2015 May;122(5):974-84. doi: 10.1097/ALN.0000000000000614.

    PMID: 25668411BACKGROUND
  • McCormick ZL, Nelson A, Bhave M, Zhukalin M, Kendall M, McCarthy RJ, Khan D, Nagpal G, Walega DR. A Prospective Randomized Comparative Trial of Targeted Steroid Injection Via Epidural Catheter Versus Standard C7-T1 Interlaminar Approach for the Treatment of Unilateral Cervical Radicular Pain. Reg Anesth Pain Med. 2017 Jan-Feb;42(1):82-89. doi: 10.1097/AAP.0000000000000521.

    PMID: 27922950BACKGROUND
  • Ackerman WE 3rd, Ahmad M. The efficacy of lumbar epidural steroid injections in patients with lumbar disc herniations. Anesth Analg. 2007 May;104(5):1217-22, tables of contents. doi: 10.1213/01.ane.0000260307.16555.7f.

    PMID: 17456677BACKGROUND
  • Gharibo CG, Varlotta GP, Rhame EE, Liu EC, Bendo JA, Perloff MD. Interlaminar versus transforaminal epidural steroids for the treatment of subacute lumbar radicular pain: a randomized, blinded, prospective outcome study. Pain Physician. 2011 Nov-Dec;14(6):499-511.

    PMID: 22086091BACKGROUND
  • Schaufele MK, Hatch L, Jones W. Interlaminar versus transforaminal epidural injections for the treatment of symptomatic lumbar intervertebral disc herniations. Pain Physician. 2006 Oct;9(4):361-6.

    PMID: 17066121BACKGROUND
  • Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Focus article: report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Eur Spine J. 2014 Oct;23(10):2028-45. doi: 10.1007/s00586-014-3540-3.

    PMID: 25212440BACKGROUND
  • Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009 Dec;146(3):238-244. doi: 10.1016/j.pain.2009.08.019.

    PMID: 19836888BACKGROUND
  • Kovacs FM, Abraira V, Royuela A, Corcoll J, Alegre L, Tomas M, Mir MA, Cano A, Muriel A, Zamora J, Del Real MT, Gestoso M, Mufraggi N; Spanish Back Pain Research Network. Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain. BMC Musculoskelet Disord. 2008 Apr 10;9:43. doi: 10.1186/1471-2474-9-43.

    PMID: 18402665BACKGROUND
  • Gallizzi M, Gagnon C, Harden RN, Stanos S, Khan A. Medication Quantification Scale Version III: internal validation of detriment weights using a chronic pain population. Pain Pract. 2008 Jan-Feb;8(1):1-4. doi: 10.1111/j.1533-2500.2007.00163.x.

    PMID: 18211588BACKGROUND

MeSH Terms

Conditions

Radiculopathy

Interventions

DexamethasoneTriamcinolonedexamethasone 21-phosphateLidocaineTriamcinolone Acetonide

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
Dr. Zachary McCormick
Organization
University of Utah, Department of Physical Medicine and Rehabilitation

Study Officials

  • Zachary L McCormick, MD

    University of Utah

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Each subject will be randomized into a group assignment in a 1:1 manner, #1 or #2, as outlined in the Methods section
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, comparative trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Zachary L. McCormick, MD

Study Record Dates

First Submitted

December 4, 2017

First Posted

December 26, 2017

Study Start

September 15, 2017

Primary Completion

April 15, 2020

Study Completion

August 19, 2020

Last Updated

November 25, 2022

Results First Posted

March 22, 2021

Record last verified: 2022-11

Locations